|
|
Blood, 15 August 2005, Vol. 106, No. 4, pp. 1189-1198.
Prepublished online as a Blood First Edition Paper on May 5, 2005; DOI 10.1182/blood-2004-12-4938.
 Previous Article | Table of Contents | Next Article 
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Global approach to the diagnosis of leukemia using gene expression profiling
Torsten Haferlach,
Alexander Kohlmann,
Susanne Schnittger,
Martin Dugas,
Wolfgang Hiddemann,
Wolfgang Kern, and
Claudia Schoch
From the Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-University, Munich, Germany; and the Department of Medical Informatics, Biometrics and Epidemiology, Ludwig-Maximilians-University, Munich, Germany.
Accurate diagnosis and classification of leukemias are the bases for the appropriate management of patients. The diagnostic accuracy and efficiency of present methods may be improved by the use of microarrays for gene expression profiling. We analyzed gene expression profiles in 937 bone marrow and peripheral blood samples from 892 patients with all clinically relevant leukemia subtypes and from 45 nonleukemic controls by U133A and U133B GeneChip arrays. For each subgroup, differentially expressed genes were calculated. Class prediction was performed using support vector machines. Prediction accuracy was estimated by 10-fold cross-validation and was assessed for robustness in a 100-fold resampling approach using randomly chosen test sets consisting of one third of the samples. Applying the top 100 genes of each subgroup, an overall prediction accuracy of 95.1% was achieved that was confirmed by resampling (median, 93.8%; 95% confidence interval, 91.4%-95.8%). In particular, acute myeloid leukemia (AML) with t(15;17), AML with t(8;21), AML with inv(16), chronic lymphatic leukemia (CLL), and pro–B-cell acute lymphoblastic leukemia (pro–B-ALL) with t(11q23) were classified with 100% sensitivity and 100% specificity. Accordingly, cluster analysis completely separated all 13 subgroups analyzed. Gene expression profiling can predict all clinically relevant subentities of leukemia with high accuracy.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
L. Bullinger, K. Dohner, R. Kranz, C. Stirner, S. Frohling, C. Scholl, Y. H. Kim, R. F. Schlenk, R. Tibshirani, H. Dohner, et al.
An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML
Blood,
May 1, 2008;
111(9):
4490 - 4495.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Wandt, U. Schakel, F. Kroschinsky, G. Prange-Krex, B. Mohr, C. Thiede, U. Pascheberg, S. Soucek, M. Schaich, and G. Ehninger
MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients
Blood,
February 15, 2008;
111(4):
1855 - 1861.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. P. S. Rawat, S. Thoene, V. M. Naidu, N. Arseni, B. Heilmeier, K. Metzeler, K. Petropoulos, A. Deshpande, L. Quintanilla-Martinez, S. K. Bohlander, et al.
Overexpression of CDX2 perturbs HOX gene expression in murine progenitors depending on its N-terminal domain and is closely correlated with deregulated HOX gene expression in human acute myeloid leukemia
Blood,
January 1, 2008;
111(1):
309 - 319.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Flotho, E. Coustan-Smith, D. Pei, C. Cheng, G. Song, C.-H. Pui, J. R. Downing, and D. Campana
A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia
Blood,
August 15, 2007;
110(4):
1271 - 1277.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Bullinger, F. G. Rucker, S. Kurz, J. Du, C. Scholl, S. Sander, A. Corbacioglu, C. Lottaz, J. Krauter, S. Frohling, et al.
Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia
Blood,
August 15, 2007;
110(4):
1291 - 1300.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cuadros, S. S. Dave, E. S. Jaffe, E. Honrado, R. Milne, J. Alves, J. Rodriguez, M. Zajac, J. Benitez, L. M. Staudt, et al.
Identification of a Proliferation Signature Related to Survival in Nodal Peripheral T-Cell Lymphomas
J. Clin. Oncol.,
August 1, 2007;
25(22):
3321 - 3329.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Yuan, J. E. Payton, M. S. Holt, D. C. Link, M. A. Watson, J. F. DiPersio, and T. J. Ley
Commonly dysregulated genes in murine APL cells
Blood,
February 1, 2007;
109(3):
961 - 970.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Greiner, M. Schmitt, L. Li, K. Giannopoulos, K. Bosch, A. Schmitt, K. Dohner, R. F. Schlenk, J. R. Pollack, H. Dohner, et al.
Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches
Blood,
December 15, 2006;
108(13):
4109 - 4117.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Lee, J. Chen, G. Zhou, R. Z. Shi, G. G. Bouffard, M. Kocherginsky, X. Ge, M. Sun, N. Jayathilaka, Y. C. Kim, et al.
Gene expression profiles in acute myeloid leukemia with common translocations using SAGE
PNAS,
January 24, 2006;
103(4):
1030 - 1035.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Mrozek and C. D. Bloomfield
Chromosome Aberrations, Gene Mutations and Expression Changes, and Prognosis in Adult Acute Myeloid Leukemia
Hematology,
January 1, 2006;
2006(1):
169 - 177.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Andersson, T. Olofsson, D. Lindgren, B. Nilsson, C. Ritz, P. Eden, C. Lassen, J. Rade, M. Fontes, H. Morse, et al.
Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations
PNAS,
December 27, 2005;
102(52):
19069 - 19074.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
